{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:25:32Z","timestamp":1787689532421,"version":"build-2784847793"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Project of Bengbu Medical University","award":["2024byzd390"],"award-info":[{"award-number":["2024byzd390"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Insulin resistance (IR) constitutes a significant pathological mechanism in chronic kidney disease (CKD) progression among individuals with diabetes. This study investigated the association between six non-insulin-dependent IR surrogate indexes and CKD risk in diabetic patients and evaluated their predictive performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Using data from the China Health and Retirement Longitudinal Study (CHARLS), multivariate Cox regression and nonlinear relationship analysis were employed to assess the association between non-insulin-dependent IR surrogate markers and CKD risk in diabetic population. Additionally, we assessed the predictive ability of each IR index by calculating the area under the curve (AUC), continuous net reclassification improvement (cNRI), and integrated discrimination improvement (IDI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 3,403 eligible participants were enrolled. Multivariate Cox analysis and Kaplan-Meier survival analysis demonstrated that CKD risk in the diabetic population increased with elevated of all IR indexes except eGDR. After adjusting for multiple confounders, estimated glucose disposal rate (eGDR) as a continuous variable revealed an inverse association with CKD risk [HR (95% CI): 0.914 (0.876, 0.954)]. Similarly, the highest eGDR quartile (Q4) maintained a significant protective association with CKD [HR (95% CI): 0.644 (0.488, 0.849] when analyzed by quartiles. All indexes demonstrated modest predictive performance, with eGDR showed the highest AUC, cNRI, and IDI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>All IR surrogate indexes demonstrated significant associations with CKD risk in diabetic populations. The eGDR showed relatively better performance for CKD risk assessment, although the overall discriminative ability of all markers was modest in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-026-02362-3","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:26:17Z","timestamp":1782440777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-insulin-dependent insulin resistance surrogate indexes for predicting chronic kidney disease in diabetic individuals: a prospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaodie","family":"Mu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"1","key":"2362_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41581-024-00889-z","volume":"21","author":"V Miguel","year":"2025","unstructured":"Miguel V, Shaw IW, Kramann R. Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease. Nat Rev Nephrol. 2025;21(1):39\u201356.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"2362_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s12916-024-03582-x","volume":"22","author":"J Peng","year":"2024","unstructured":"Peng J, et al. Estimated glucose disposal rate for predicting cardiovascular events and mortality in patients with non-diabetic chronic kidney disease: a prospective cohort study. BMC Med. 2024;22(1):411.","journal-title":"BMC Med"},{"key":"2362_CR3","doi-asserted-by":"publisher","first-page":"1513008","DOI":"10.3389\/fendo.2025.1513008","volume":"16","author":"X Ma","year":"2025","unstructured":"Ma X, Liu R, Xi X, Zhuo H, Gu Y. Global burden of chronic kidney disease due to diabetes mellitus, 1990\u20132021, and projections to 2050. Front Endocrinol (Lausanne). 2025;16:1513008.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"2362_CR4","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41581-021-00454-y","volume":"17","author":"E Brennan","year":"2021","unstructured":"Brennan E, Kantharidis P, Cooper ME, Godson C. Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function. Nat Rev Nephrol. 2021;17(11):725\u201339.","journal-title":"Nat Rev Nephrol"},{"issue":"10440","key":"2362_CR5","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"Global burden and strength of evidence for","year":"2024","unstructured":"Global burden and strength of evidence for. 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2162\u2013203.","journal-title":"Lancet"},{"issue":"1","key":"2362_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12933-023-01791-x","volume":"22","author":"W Linn","year":"2023","unstructured":"Linn W, et al. Estimated glucose disposal rate is associated with retinopathy and kidney disease in young people with type 1 diabetes: a nationwide observational study. Cardiovasc Diabetol. 2023;22(1):61.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2362_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12933-025-02589-9","volume":"24","author":"G Zheng","year":"2025","unstructured":"Zheng G, et al. Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):22.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2362_CR8","doi-asserted-by":"publisher","first-page":"e1106","DOI":"10.1210\/clinem\/dgab767","volume":"107","author":"A Delai","year":"2022","unstructured":"Delai A, et al. Hyperinsulinemic-Euglycemic Clamp Strengthens the Insulin Resistance in Nonclassical Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2022;107(3):e1106\u201316.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2362_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12933-025-02618-7","volume":"24","author":"L Jiang","year":"2025","unstructured":"Jiang L, et al. Assessment of six insulin resistance surrogate indexes for predicting stroke incidence in Chinese middle-aged and elderly populations with abnormal glucose metabolism: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):56.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2362_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12933-025-02729-1","volume":"24","author":"B Dong","year":"2025","unstructured":"Dong B, et al. Estimated glucose disposal rate outperforms other insulin resistance surrogates in predicting incident cardiovascular diseases in cardiovascular-kidney-metabolic syndrome stages 0\u20133 and the development of a machine learning prediction model: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):163.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2362_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2012;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"issue":"33","key":"2362_CR12","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"issue":"1","key":"2362_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12933-024-02256-5","volume":"23","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Zhao L, Lu Y, Xiao Y, Zhou X. Insulin resistance assessed by estimated glucose disposal rate and risk of incident cardiovascular diseases among individuals without diabetes: findings from a nationwide, population based, prospective cohort study. Cardiovasc Diabetol. 2024;23(1):194.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2362_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12933-022-01548-y","volume":"21","author":"J Zhao","year":"2022","unstructured":"Zhao J, et al. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol. 2022;21(1):123.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2362_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12944-024-02045-9","volume":"23","author":"R Wang","year":"2024","unstructured":"Wang R, Chen C, Xu G, Jin Z. Association of triglyceride glucose-body mass index and hemoglobin glycation index with heart failure prevalence in hypertensive populations: a study across different glucose metabolism status. Lipids Health Dis. 2024;23(1):53.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2362_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12933-024-02334-8","volume":"23","author":"M Duan","year":"2024","unstructured":"Duan M, et al. Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2024;23(1):243.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2362_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12933-024-02570-y","volume":"24","author":"J Liao","year":"2025","unstructured":"Liao J, et al. Association between estimated glucose disposal rate and cardiovascular diseases in patients with diabetes or prediabetes: a cross-sectional study. Cardiovasc Diabetol. 2025;24(1):13.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2362_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12933-024-02518-2","volume":"23","author":"Y Yang","year":"2024","unstructured":"Yang Y, et al. The interaction between triglyceride-glucose index and visceral adiposity in cardiovascular disease risk: findings from a nationwide Chinese cohort. Cardiovasc Diabetol. 2024;23(1):427.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2362_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12933-023-01886-5","volume":"22","author":"B Yin","year":"2023","unstructured":"Yin B, et al. Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2023;22(1):157.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"2362_CR20","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1097\/HJH.0000000000003259","volume":"40","author":"X Zheng","year":"2022","unstructured":"Zheng X, Han L, Shen S. Hypertension, remnant cholesterol and cardiovascular disease: evidence from the China health and retirement longitudinal study. J Hypertens. 2022;40(11):2292\u20138.","journal-title":"J Hypertens"},{"issue":"1","key":"2362_CR21","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1186\/s12877-022-03689-x","volume":"22","author":"X Ren","year":"2022","unstructured":"Ren X, Jiang M, Han L, Zheng X. Estimated glucose disposal rate and risk of cardiovascular disease: evidence from the China Health and Retirement Longitudinal Study. BMC Geriatr. 2022;22(1):968.","journal-title":"BMC Geriatr"},{"key":"2362_CR22","doi-asserted-by":"crossref","unstructured":"Saran R, et al. US renal data system 2019 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2020;75(1 Suppl 1):A6\u20137.","DOI":"10.1053\/j.ajkd.2019.09.003"},{"issue":"1","key":"2362_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12916-021-01936-3","volume":"19","author":"G Penno","year":"2021","unstructured":"Penno G, et al. Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study. BMC Med. 2021;19(1):66.","journal-title":"BMC Med"},{"issue":"1","key":"2362_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12933-025-02671-2","volume":"24","author":"M Sbriscia","year":"2025","unstructured":"Sbriscia M, et al. Triglyceride glucose index predicts long-term mortality and major adverse cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2025;24(1):115.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2362_CR25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2337\/dc23-1420","volume":"47","author":"T Ebert","year":"2024","unstructured":"Ebert T, et al. Outcomes With Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Insulin Resistance. Diabetes Care. 2024;47(3):362\u201370.","journal-title":"Diabetes Care"},{"issue":"3","key":"2362_CR26","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1002\/j.2040-4603.2023.tb00269.x","volume":"13","author":"K Uehara","year":"2023","unstructured":"Uehara K, Santoleri D, Whitlock AEG, Titchenell PM. Insulin Regulation of Hepatic Lipid Homeostasis. Compr Physiol. 2023;13(3):4785\u2013809.","journal-title":"Compr Physiol"},{"issue":"1","key":"2362_CR27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12020-023-03574-6","volume":"84","author":"X Mu","year":"2024","unstructured":"Mu X, Wu A, Hu H, Yang M, Zhou H. Correlation between alternative insulin resistance indexes and diabetic kidney disease: a retrospective study. Endocrine. 2024;84(1):136\u201347.","journal-title":"Endocrine"},{"issue":"1","key":"2362_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2023;22(1):279.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2362_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12933-023-01898-1","volume":"22","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhao L, Lu Y, Meng X, Zhou X. Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol. 2023;22(1):161.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2362_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12933-024-02228-9","volume":"23","author":"H Yan","year":"2024","unstructured":"Yan H, et al. Associations between cardiometabolic indices and the risk of diabetic kidney disease in patients with type 2 diabetes. Cardiovasc Diabetol. 2024;23(1):142.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2362_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12933-023-01762-2","volume":"22","author":"B Che","year":"2023","unstructured":"Che B, et al. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol. 2023;22(1):34.","journal-title":"Cardiovasc Diabetol"},{"key":"2362_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2024.08.026","volume":"131","author":"Y Sun","year":"2025","unstructured":"Sun Y, Ji H, Sun W, An X, Lian F. Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases. Eur J Intern Med. 2025;131:3\u201314.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"2362_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"key":"2362_CR34","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.2147\/DMSO.S477836","volume":"17","author":"N Huang","year":"2024","unstructured":"Huang N, et al. The Association Between Triglyceride Glucose-Body Mass Index and Kidney Impairment in Patients with Type 2 Diabetes Mellitus. Diabetes Metab Syndr Obes. 2024;17:3447\u201353.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2362_CR35","doi-asserted-by":"publisher","first-page":"1505808","DOI":"10.3389\/fendo.2025.1505808","volume":"16","author":"Y Wu","year":"2025","unstructured":"Wu Y, Liu C, Cao J. Association between triglyceride-glucose index and its composite obesity indexes and cardio-renal disease: analysis of the NHANES 2013\u20132018 cycle. Front Endocrinol (Lausanne). 2025;16:1505808.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2362_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/EJE-17-0883","volume":"178","author":"OY Bello-Chavolla","year":"2018","unstructured":"Bello-Chavolla OY, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533\u201344.","journal-title":"Eur J Endocrinol"},{"key":"2362_CR37","doi-asserted-by":"publisher","first-page":"1175988","DOI":"10.3389\/fendo.2023.1175988","volume":"14","author":"Q Xie","year":"2023","unstructured":"Xie Q, et al. Association between MetS-IR and prediabetes risk and sex differences: a cohort study based on the Chinese population. Front Endocrinol (Lausanne). 2023;14:1175988.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2362_CR38","doi-asserted-by":"publisher","first-page":"1027262","DOI":"10.3389\/fendo.2022.1027262","volume":"13","author":"G Liu","year":"2022","unstructured":"Liu G, et al. Association between the metabolic score for insulin resistance (METS-IR) and estimated glomerular filtration rate (eGFR) among health check-up population in Japan: A retrospective cross-sectional study. Front Endocrinol (Lausanne). 2022;13:1027262.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2362_CR39","doi-asserted-by":"publisher","first-page":"e005137","DOI":"10.1136\/bmjdrc-2025-005137","volume":"13","author":"G Yang","year":"2025","unstructured":"Yang G, et al. Influence of metabolism-related comorbidities and insulin resistance on new onset of chronic kidney disease in a health check-up population: a two-stage retrospective cohort study. BMJ Open Diabetes Res Care. 2025;13(4):e005137.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"2362_CR40","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12872-022-02817-0","volume":"22","author":"J Xuan","year":"2022","unstructured":"Xuan J, Juan D, Yuyu N, Anjing J. Impact of estimated glucose disposal rate for identifying prevalent ischemic heart disease: findings from a cross-sectional study. BMC Cardiovasc Disord. 2022;22(1):378.","journal-title":"BMC Cardiovasc Disord"},{"key":"2362_CR41","doi-asserted-by":"publisher","first-page":"1507735","DOI":"10.3389\/fendo.2025.1507735","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu Y, Liu M, Jiang Y, Cui S, Tang W. Association of estimated glucose disposal rate with chronic kidney disease: comparative analysis against traditional insulin resistance indices. Front Endocrinol (Lausanne). 2025;16:1507735.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2362_CR42","doi-asserted-by":"publisher","first-page":"e3764","DOI":"10.1002\/dmrr.3764","volume":"40","author":"D Xiao","year":"2024","unstructured":"Xiao D, et al. Assessment of six surrogate insulin resistance indexes for predicting cardiometabolic multimorbidity incidence in Chinese middle-aged and older populations: Insights from the China health and retirement longitudinal study. Diabetes Metab Res Rev. 2024;40(1):e3764.","journal-title":"Diabetes Metab Res Rev"},{"issue":"9","key":"2362_CR43","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.3390\/nu15092146","volume":"15","author":"Y Li","year":"2023","unstructured":"Li Y, et al. Comparison of Several Adiposity Indexes in Predicting Hypertension among Chinese Adults: Data from China Nutrition and Health Surveillance (2015\u20132017). Nutrients. 2023;15(9):2146.","journal-title":"Nutrients"},{"issue":"10","key":"2362_CR44","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41574-025-01142-8","volume":"21","author":"G Wang","year":"2025","unstructured":"Wang G, Song A, Wang QA. Adipose tissue ageing: implications for metabolic health and lifespan. Nat Rev Endocrinol. 2025;21(10):623\u201337.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2362_CR45","doi-asserted-by":"publisher","first-page":"e15464","DOI":"10.1111\/dme.15464","volume":"42","author":"N Fountoulakis","year":"2024","unstructured":"Fountoulakis N, Miyamoto Y, Pavkov ME, Karalliedde J, Maltese G. Pathophysiology of vascular ageing and the effect of novel cardio-renal protective medications in preventing progression of chronic kidney disease in people living with diabetes. Diabet Med. 2024;42(2):e15464.","journal-title":"Diabet Med"},{"issue":"10","key":"2362_CR46","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/iju.70158","volume":"32","author":"E Kashiwagi","year":"2025","unstructured":"Kashiwagi E. Perirenal Fat in Disease Progression: From Inflammatory Mediator to Therapeutic Target. Int J Urol. 2025;32(10):1314\u201320.","journal-title":"Int J Urol"},{"issue":"1","key":"2362_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12933-024-02198-y","volume":"23","author":"M Rabiee Rad","year":"2024","unstructured":"Rabiee Rad M, Ghasempour Dabaghi G, Darouei B, Amani-Beni R. The association of atherogenic index of plasma with cardiovascular outcomes in patients with coronary artery disease: A systematic review and meta-analysis. Cardiovasc Diabetol. 2024;23(1):119.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2362_CR48","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12944-024-02288-6","volume":"23","author":"B Wang","year":"2024","unstructured":"Wang B, et al. Nonlinear association between atherogenic index of plasma and chronic kidney disease: a nationwide cross-sectional study. Lipids Health Dis. 2024;23(1):312.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2362_CR49","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1186\/s12889-025-22087-7","volume":"25","author":"Y Wang","year":"2025","unstructured":"Wang Y, et al. Gender disparities in the association between atherogenic index of plasma and chronic kidney disease. BMC Public Health. 2025;25(1):825.","journal-title":"BMC Public Health"},{"issue":"3","key":"2362_CR50","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2337\/dc17-1237","volume":"41","author":"AM Hung","year":"2018","unstructured":"Hung AM, et al. Risk of Hypoglycemia Following Hospital Discharge in Patients With Diabetes and Acute Kidney Injury. Diabetes Care. 2018;41(3):503\u201312.","journal-title":"Diabetes Care"},{"issue":"6","key":"2362_CR51","doi-asserted-by":"publisher","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","volume":"311","author":"B Spoto","year":"2016","unstructured":"Spoto B, Pisano A, Zoccali C. Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Ren Physiol. 2016;311(6):F1087\u2013108.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"2","key":"2362_CR52","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jfma.2024.12.007","volume":"125","author":"J-J Chen","year":"2024","unstructured":"Chen J-J, et al. Non-recovery acute kidney injury and additional risk factors for short-term and long-term hypoglycemia: A multi-institutional cohort study. J Formos Med Assoc. 2024;125(2):147\u201354.","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"2362_CR53","doi-asserted-by":"publisher","first-page":"16746","DOI":"10.1038\/s41598-024-67678-3","volume":"14","author":"C-T Huang","year":"2024","unstructured":"Huang C-T, Muo C-H, Sung F-C, Chen P-C. Risk of chronic kidney disease in patients with a hyperglycemic crisis as the initial presentation of type 2 diabetes. Sci Rep. 2024;14(1):16746.","journal-title":"Sci Rep"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02362-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02362-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02362-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:02:33Z","timestamp":1787688153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02362-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2362"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02362-3","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The institutional review board of Peking University approved the study protocol (IRB 00001052\u201311015) in accordance with the Declaration of Helsinki. All participants signed informed consent.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"247"}}